Ovid Therapeutics Inc.
DE ˙ DB ˙ US6904691010
2,02 € ↑0,02 (1,00%)
2026-06-04
AKTIENPREIS
SecurityDE:1OT / Ovid Therapeutics Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership49,555 shares
Latest Disclosed Value $ 110,012
Morgan Stanley reports 34.11% increase in ownership of 1OT / Ovid Therapeutics Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 49,555 shares of Ovid Therapeutics Inc. (DE:1OT) valued at $89,199 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 36,952 shares of Ovid Therapeutics Inc.. This represents a change in shares of 34.11% during the quarter. The current value of the position is $100,101 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F OVID THERAPEUTICS COM 690469101 49,555 12,603 34.11 110 83.33 0.0000
2026-05-27 2025-12-31 13F/A-1 OVID THERAPEUTICS COM 690469101 36,952 34,638 1,496.89 60 1,900.00 0.0000
2026-02-13 2025-12-31 13F OVID THERAPEUTICS COM 690469101 36,952 34,638 60 0.0000
2026-05-27 2025-09-30 13F/A-1 OVID THERAPEUTICS COM 690469101 2,314 -8,251 -78.10 3 0.00 0.0000
2025-11-14 2025-09-30 13F OVID THERAPEUTICS COM 690469101 2,314 -8,251 3 0.0000
2025-08-15 2025-06-30 13F OVID THERAPEUTICS COM 690469101 10,565 -72,162 -87.23 3 -88.00 0.0000
2025-05-15 2025-03-31 13F OVID THERAPEUTICS COM 690469101 82,727 -106,760 -56.34 26 -85.80 0.0000
2025-05-15 2024-12-31 13F/A-1 OVID THERAPEUTICS COM 690469101 189,487 23,657 14.27 177 -9.74 0.0000
2025-02-14 2024-12-31 13F OVID THERAPEUTICS COM 690469101 189,487 23,657 177 0.0000
2025-05-14 2024-09-30 13F/A-2 OVID THERAPEUTICS COM 690469101 165,830 96,880 140.51 196 267.92 0.0000
2025-02-14 2024-09-30 13F/A-1 OVID THERAPEUTICS COM 690469101 165,830 96,880 196 0.0000
2024-11-14 2024-09-30 13F OVID THERAPEUTICS COM 690469101 165,830 96,880 196 0.0000
2025-05-14 2024-06-30 13F/A-2 OVID THERAPEUTICS COM 690469101 68,950 -31,003 -31.02 53 -82.57 0.0000
2024-10-17 2024-06-30 13F/A-1 OVID THERAPEUTICS COM 690469101 68,950 -31,003 53 0.0000
2024-08-14 2024-06-30 13F OVID THERAPEUTICS COM 690469101 68,950 -31,003 53 0.0000
2024-10-17 2024-03-31 13F/A-2 OVID THERAPEUTICS COM 690469101 99,953 -33,987 -25.37 305 -29.47 0.0000
2024-08-16 2024-03-31 13F/A-1 OVID THERAPEUTICS COM 690469101 99,953 -33,987 305 0.0000
2024-05-15 2024-03-31 13F OVID THERAPEUTICS COM 690469101 99,953 -33,987 305 0.0000
2024-08-16 2023-12-31 13F/A-1 OVID THERAPEUTICS COM 690469101 133,940 90,823 210.64 431 161.21 0.0000
2024-02-13 2023-12-31 13F OVID THERAPEUTICS COM 690469101 133,940 90,823 431 0.0000
2023-11-15 2023-09-30 13F OVID THERAPEUTICS COM 690469101 43,117 -10,527 -19.62 166 -5.71 0.0000
2023-08-14 2023-06-30 13F OVID THERAPEUTICS COM 690469101 53,644 20,782 63.24 176 108.33 0.0000
2023-05-15 2023-03-31 13F OVID THERAPEUTICS COM 690469101 32,862 29,321 828.04 85 1,300.00 0.0000
2023-02-14 2022-12-31 13F OVID THERAPEUTICS COM 690469101 3,541 -12,518 -77.95 7 -80.00 0.0000
2022-11-14 2022-09-30 13F OVID THERAPEUTICS COM 690469101 16,059 -4,812 -23.06 30 -33.33 0.0000
2022-10-27 2022-06-30 13F/A-1 OVID THERAPEUTICS COM 690469101 20,871 1,801 9.44 45 -25.00 0.0000
2022-08-15 2022-06-30 13F OVID THERAPEUTICS COM 690469101 20,871 1,801 45 0.0000
2022-10-27 2022-03-31 13F/A-1 OVID THERAPEUTICS COM 690469101 19,070 -2,395 -11.16 60 -13.04 0.0000
2022-05-13 2022-03-31 13F OVID THERAPEUTICS COM 690469101 19,070 -2,395 60 0.0000
2022-02-14 2021-12-31 13F OVID THERAPEUTICS COM 690469101 21,465 -23,969 -52.76 69 -54.90 0.0000
2021-11-15 2021-09-30 13F OVID THERAPEUTICS COM 690469101 45,434 -144,766 -76.11 153 -79.41 0.0000
2021-08-23 2021-06-30 13F/A-1 OVID THERAPEUTICS COM 690469101 190,200 112,266 144.05 743 136.62 0.0001
2021-08-16 2021-06-30 13F OVID THERAPEUTICS COM 690469101 190,200 112,266 743 0.0000
2021-05-17 2021-03-31 13F OVID THERAPEUTICS COM 690469101 77,934 -72,179 -48.08 314 -9.51 0.0000
2021-02-16 2020-12-31 13F OVID THERAPEUTICS COM 690469101 150,113 20,587 15.89 347 -53.36 0.0001
2020-11-13 2020-09-30 13F OVID THERAPEUTICS COM 690469101 129,526 -21,361 -14.16 744 -33.15 0.0001
2020-08-14 2020-06-30 13F OVID THERAPEUTICS COM 690469101 150,887 28,826 23.62 1,113 205.77 0.0002
2020-05-26 2020-03-31 13F/A-1 OVID THERAPEUTICS COM 690469101 122,061 -220,115 -64.33 364 -74.37 0.0001
2020-05-15 2020-03-31 13F OVID THERAPEUTICS COM 690469101 122,061 -220,115 364 27.9628
2020-02-14 2019-12-31 13F OVID THERAPEUTICS COM 690469101 342,176 282,933 477.58 1,420 639.58 0.0003
2019-11-14 2019-09-30 13F OVID THERAPEUTICS COM 690469101 59,243 7,169 13.77 192 100.00 0.0001
2019-08-14 2019-06-30 13F OVID THERAPEUTICS COM 690469101 52,074 -73,832 -58.64 96 -57.14 0.0000
2019-05-15 2019-03-31 13F OVID THERAPEUTICS COM 690469101 125,906 87,238 225.61 224 140.86 0.0001
2019-02-14 2018-12-31 13F OVID THERAPEUTICS COM 690469101 38,668 -13,099 -25.30 93 -68.26 0.0000
2019-04-23 2018-09-30 13F/A-2 OVID THERAPEUTICS COM 690469101 51,767 23,105 80.61 293 31.39 0.0001
2018-11-20 2018-09-30 13F/A-1 OVID THERAPEUTICS COM 690469101 51,767 0 293 0.0001
2018-11-14 2018-09-30 13F OVID THERAPEUTICS COM 690469101 51,767 23,105 293
2019-04-23 2018-06-30 13F/A-1 OVID THERAPEUTICS COM 690469101 28,662 991 3.58 223 13.78 0.0001
2018-08-14 2018-06-30 13F OVID THERAPEUTICS COM 690469101 28,662 991 223
2019-04-23 2018-03-31 13F/A-1 OVID THERAPEUTICS COM 690469101 27,671 1,014 3.80 196 -25.76 0.0001
2018-05-14 2018-03-31 13F OVID THERAPEUTICS COM 690469101 27,671 1,014 196
2019-04-23 2017-12-31 13F/A-1 OVID THERAPEUTICS COM 690469101 26,657 19,752 286.05 264 347.46 0.0001
2018-02-14 2017-12-31 13F OVID THERAPEUTICS COM 690469101 26,657 19,752 264
2017-11-14 2017-09-30 13F OVID THERAPEUTICS COM 690469101 6,905 1,848 36.54 59 11.32 0.0000
2017-08-11 2017-06-30 13F OVID THERAPEUTICS COM 690469101 5,057 5,057 53 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.